Top Factor Driving Pharmacovigilance Market Growth in 2025: Research And Development Drive Growth In The Pharmacovigilance Market

How Are the key drivers contributing to the expansion of the pharmacovigilance market?
The escalation in research and development undertakings stimulates growth in the pharmacovigilance market. Pharmaceutical organizations can create novel and superior drugs through enhanced safety profiles by allocating resources to R&D. The intensive testing in preclinical and clinical stages during the drug development protocol allows early recognition of potential safety issues, paving the way for adequate risk reduction approaches. Moreover, R&D initiatives help in progressing technologies for monitoring adverse events, analyzing data, and detecting signals, enabling the quick identification of adverse drug reactions in the post-marketing phase. For instance, as revealed by the Llywodraeth Cymru Welsh Government, a UK governmental entity, in February 2024, Wales committed £1.0 billion ($1.25 billion) to Business Expenditure on Research and Development (BERD) in 2022, representing 1.9% of the entire UK spending in this sector. Hence, the acceleration in research and development activities nurtured the expansion of the pharmacovigilance market.

Get Your Pharmacovigilance Market Report Here:
https://www.thebusinessresearchcompany.com/report/pharmacovigilance-global-market-report

What growth opportunities are expected to drive the pharmacovigilance market's CAGR through 2034?
In recent times, there has been a swift expansion in the size of the pharmacovigilance market. It is projected to escalate from a value of $8.58 billion in 2024 to reach $9.73 billion by 2025, demonstrating a compound annual growth rate (CAGR) of 13.5%. This impressive growth during the historic period can be linked to multiple factors such as an increasing occurrence of adverse drug reactions (ADRs), elevated levels of research and development (R&D) activities, rising drug development rates, a growing emphasis on personalized medicine, and a heightened prevalence of chronic diseases.

The market size of pharmacovigilance is anticipated to witness accelerated growth in the upcoming years. It is predicted to elevate to $15.83 billion by 2029, with a compound annual growth rate (CAGR) of 12.9%. The surge during this forecast period is likely due to enhanced healthcare spending, increased support from the government, and an aging population. The forecast period will also see significant trends including rising investments, the deployment of artificial intelligence, the utilization of inventive platforms and cloud-based systems, and strategical mergers and acquisitions.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=5928&type=smp

What new trends are reshaping the pharmacovigilance market and its opportunities?
Firms in the pharmacovigilance sector are increasingly focusing on the use of artificial intelligence (AI) to enhance their efficiency. AI has the potential to refine the precision and effectiveness of pharmacovigilance operations, contributing to better results for patients. Through the adoption of AI, pharmaceutical firms can make their procedures more efficient, upgrade their data management processes, and expedite drug discovery. At the same time, it helps lower costs and improve safety measures. For instance, the Government of India initiated the Adverse Drug Reaction Monitoring System (ADRMS) software in August 2024. Gathering and analysing adverse events related to medications and medical devices, this pharmacovigilance software, introduced by the Minister of Health & Family Welfare and Minister of Chemicals and Fertilizers, simplifies the reporting procedure for both healthcare professionals and patients. It significantly enhances India's pharmacovigilance infrastructure by ensuring comprehensive data collection and strengthening drug safety monitoring. By promoting adherence to regulations and enhancing pharmacovigilance, the ADRMS is contributing to establishing India's reputation in the worldwide pharmaceutical industry.

Which growth-oriented segments of the pharmacovigilance market are leading the industry's development?
The pharmacovigilance market covered in this report is segmented -

1) By Type: Spontaneous Reporting, Intensified ADR Reporting, Targeted Spontaneous Reporting, Cohort Event Monitoring, EHR Mining
2) By Service Provider: In-House, Contract Outsourcing
3) By Process Flow: Case Data Management, Signal Detection, Risk Management System
4) By Clinical Trial Phases: Preclinical, Phase I, Phase II, Phase III, Phase IV
5) By End User: Hospitals, Pharmaceutical Companies, Other End Users

Subsegments:
1) By Spontaneous Reporting: Individual Case Safety Reports (ICSRs), Voluntary Reporting Systems, Case Reports From Healthcare Professionals
2) By Intensified ADR Reporting: Active Surveillance Programs, Enhanced Monitoring In Clinical Trials, Risk Minimization Strategies
3) By Targeted Spontaneous Reporting: Reporting For Specific Drug Classes, Condition-Specific Reporting, Focused Surveillance Programs
4) By Cohort Event Monitoring: Prospective Cohort Studies, Retrospective Cohort Studies, Longitudinal Studies
5) By EHR Mining: Data Extraction From Electronic Health Records, Signal Detection Through EHR Analysis, Integration Of EHR Data With Pharmacovigilance Systems

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=5928

What regions are leading the charge in the pharmacovigilance market?
North America was the largest region in the pharmacovigilance market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast region. The regions covered in the pharmacovigilance market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What companies are at the forefront of innovation in the pharmacovigilance market?
Major companies operating in the pharmacovigilance market include IQVIA, Cognizant, ICON Plc, plc, PAREXEL International Corporation., United BioSource LLC, ArisGlobal, Quanticate, Wipro Limited, Linical Americas, Novotech CRO, Wuxi Apptec, Simcere Pharmaceutical Group, Lee's Pharmaceutical Holdings, Luye Pharma Group, EXTEDO, Arriello, PrimeVigilance, Axios International, C3i Solutions, Alcon, Secure AI Labs, OmniSol dot Tech, Canna Call Company, Veripad, Prevnos Inc., Lifescient, Inc, BeiGene, QuintilesIMS, Labcorp Drug Development, Pharmaceutical Product Development Inc., PRA Health Sciences, Synowledge LLC, RAPAhub, illuminate health, Invenio Medical, ClinChoice Inc., MSD, Novasyte, Fortrea Holdings Inc, Syneos Health Clinical, Zoetis Inc., Telerx Marketing Inc., Gilead Sciences, Inc., Elanco, Abbott Laboratories, Spimaco, Teva Pharmaceutical Industries Ltd.

Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/sample.aspx?id=5928&type=smp

What Is Covered In The Pharmacovigilance Global Market Report?

• Market Size Forecast: Examine the pharmacovigilance market size across key regions, countries, product categories, and applications.
• Segmentation Insights: Identify and classify subsegments within the pharmacovigilance market for a structured understanding.
• Key Players Overview: Analyze major players in the pharmacovigilance market, including their market value, share, and competitive positioning.
• Growth Trends Exploration: Assess individual growth patterns and future opportunities in the pharmacovigilance market.
• Segment Contributions: Evaluate how different segments drive overall growth in the pharmacovigilance market.
• Growth Factors: Highlight key drivers and opportunities influencing the expansion of the pharmacovigilance market.
• Industry Challenges: Identify potential risks and obstacles affecting the pharmacovigilance market.
• Competitive Landscape: Review strategic developments in the pharmacovigilance market, including expansions, agreements, and new product launches.

Learn More About The Business Research Company
The Business Research Company provides in-depth research and insights through a vast collection of 15,000+ reports spanning 27 industries and over 60 geographies. Backed by 1,500,000 datasets, extensive secondary research, and expert insights from industry leaders, we equip you with the knowledge needed to stay ahead in the market.

Our flagship offering, the Global Market Model, is a leading market intelligence platform that delivers comprehensive and up-to-date forecasts to support strategic decision-making.

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.